Patrick Spencer, RN, OCN provides important points to cover when counseling a patient with multiple myeloma receiving treatment with daratumumab.
Patrick Spencer, RN, OCN, of Mount Sinai Medical Center, provides some important points to cover when counseling a patient with multiple myeloma receiving treatment with daratumumab.
The first day especially requires long hours of infusion. Spencer also recommends that the patient bring a caregiver with them. There can be infusion-related reactions that a patient might not normally report, such as a runny nose or itchy throat. If patients are prepared, however, and know to inform their clinicians, they can receive the proper medication to prevent such reactions from becoming severe.
Shared Model of Care Post-HCT Offers Safe Follow-Up, Reduces Patient Burden
Published: March 19th 2025 | Updated: March 19th 2025Alternating post-HCT care between specialized facilities and local cancer centers produced noninferior non-relapse mortality and similar quality of life to usual care.